Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
<p><strong>Background:</strong><br /> Prostate cancer is the most common cancer among men in the UK. Prostate-specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as undertreatment of the disease. Evidence of treatment effectiveness has la...
Main Authors: | Hamdy, FC, Donovan, JL, Lane, JA, Mason, M, Metcalfe, C, Peter Holding, Wade, J, Noble, S, Garfield, K, Young, G, Davis, M, Peters, TJ, Turner, EL, Martin, RM, Oxley, J, Robinson, M, Staffurth, J, Walsh, E, Blazeby, J, Bryant, R, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Prescott, S, Rosario, D, Rowe, E, Neal, D |
---|---|
מחברים אחרים: | ProtecT Study Group |
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
NIHR Journals Library
2020
|
פריטים דומים
-
Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT
מאת: Hamdy, F, et al.
יצא לאור: (2018) -
Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy.
מאת: Brewster, S, et al.
יצא לאור: (1999) -
Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial
מאת: Johnston, T, et al.
יצא לאור: (2016) -
Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
מאת: Neal, D, et al.
יצא לאור: (2019) -
The ProtecT trial: Analysis of the patient cohort, baseline risk stratification and disease progression
מאת: Young, GJ, et al.
יצא לאור: (2020)